At both annual and 6-monthly frequencies, US-led surveillance becomes more effective than AFP-triage surveillance when it can be assumed that US is at least sensitive enough to detect one in five small tumours, one in three medium tumours and two in three large tumours. The gene discussed is AFP; the disease is neoplasm.